Daxor Corporation, the global leader in blood volume measurement technology, has been awarded a $1.1 million contract from the United States Defense Health Agency (DHA) to add electronic medical record (EMR) integration capabilities to its blood volume analyzer. This marks the fifth Small Business Innovative Research (SBIR) contract awarded to Daxor for their next generation technologies. The integration of EMR into their device will make volume measurement easier and quicker, benefiting both military and civilian healthcare settings.
Direct blood volume measurement has been proven to improve outcomes in various acute and chronic medical conditions. By incorporating EMR integration into their small, portable, battery-powered analyzer, Daxor aims to enable caretakers and clinicians to make precise and timely decisions regarding medication administration and patient-specific treatment.
Daxor Corporation is a global leader in blood volume measurement technology. Their flagship product, the BVA-100® Blood Volume Analyzer, is the first FDA-cleared diagnostic blood test that provides objective quantification of blood volume status compared to patient-specific norms.